Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Fumiaki Ueno"'
Autor:
Hiroshi Nakase, Yuki Hayashi, Yoshihiro Yokoyama, Takayuki Matsumoto, Minoru Matsuura, Hideki Iijima, Katsuyoshi Matsuoka, Naoki Ohmiya, Shunji Ishihara, Fumihito Hirai, Daiki Abukawa, Tadakazu Hisamatsu, Makoto Sasaki, Masahiro Iizuka, Mikihiro Fujiya, Fukunori Kinjo, Shiro Nakamura, Noriko Kamata, Yuri Etani, Fumiaki Ueno, Sakiko Hiraoka, Takeo Kondo, Takashi Kagaya, Makoto Naganuma, Kiyonori Kobayashi, Taku Kobayashi, Shuji Yamamoto, Yuji Naito, Yoki Furuta, Keichi Mitsuyama, Yu Hashimoto, Katsuhiro Arai, Shingo Kato, Itaru Iwama, Motohiro Esaki, Hiroki Tanaka, Satoshi Motoya, Atsuo Maemoto, Toshifumi Ashida, Nobuaki Nishimata, Shigeaki Aono, Akira Andoh, Hironori Yamamoto, Toshiaki Shimizu, Maeda Yasuharu, Kenji Kinoshita, Katuyuki Fukuda, Jun Kato, Ken Takeuchi, Masakazu Nagahori, Masakatsu Fukuzawa, Masayuki Saruta, Takayoshi Suzuki, Michio Itabashi, Masaru Shinozaki, Soichiro Ishihara, Naoki Yoshimura, Yoichi Kakuta, Kenichi Takahashi, Keiichi Tominaga, Ryosuke Sakemi, Sohachi Nanjo, Shusaku Yoshikawa, Keiji Ozeki, Ayako Fuchigami, Takehiko Katsurada, Kenji Watanabe, Hirotake Sakuraba, Takashi Hisabe, Shigeru Iwase, Ryota Hokari, Katsuhiko Nakai, Takeshi Ueda, Shojiro Yamamoto, Kazutaka Koganei, Reiko Kunisaki, Akira Hokama
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 8, Pp 1056-1065 (2023)
Background and Aims: Japan has experienced 8 waves of the coronavirus disease 2019 (COVID-19) outbreak over the past 3 years, resulting in an increasing number of deaths and incidence of severe infections. This study aimed to analyze the data from th
Externí odkaz:
https://doaj.org/article/6dc0fa435835412099a962069329f0e1
Autor:
Atsushi Yoshida, Katsuyoshi Matsuoka, Fumiaki Ueno, Toshio Morizane, Yutaka Endo, Toshifumi Hibi
Publikováno v:
Inflammatory Intestinal Diseases, Vol 6, Iss 2, Pp 117-122 (2021)
Background: Anti-tumor necrosis factor-α (TNF-α) agents are effective for moderately to severely active ulcerative colitis (UC). Nonetheless, a proportion of patients fail to respond to these agents as therapy for induction of remission. Recent stu
Externí odkaz:
https://doaj.org/article/e637bfba8787417b88d0cd3eea53e80b
Autor:
Jun Miyoshi, Katsuyoshi Matsuoka, Atsushi Yoshida, Makoto Naganuma, Tadakazu Hisamatsu, Tomoharu Yajima, Nagamu Inoue, Susumu Okamoto, Yasushi Iwao, Haruhiko Ogata, Fumiaki Ueno, Toshifumi Hibi, Takanori Kanai
Publikováno v:
Intestinal Research, Vol 16, Iss 4, Pp 635-640 (2018)
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been demonstrated, a few patients paradoxically develop a se
Externí odkaz:
https://doaj.org/article/8d0020e2b8be4690b383973b99cbcc60
Autor:
Yutaka Susuta, Atsuo Maemoto, Toshifumi Hibi, Fumiaki Ueno, Katsuyoshi Matsuoka, Noriko Sato, Hirono Ishikawa, Yusuke Honzawa, Fumihito Hirai, Takeo Nakayama
Publikováno v:
Journal of Gastroenterology
Background The relationship of bidirectional sharing of information between physicians and patients to patient satisfaction with treatment decision-making for ulcerative colitis (UC) has not been examined. Here, we conducted a web-based survey to eva
Publikováno v:
European journal of gastroenterologyhepatology. 34(6)
It is necessary to find reliable and appropriate predictors of primary response to anti-TNFα therapy (infliximab and adalimumab) in inflammatory bowel disease (IBD) so as to avoid treatment failure and select optimal treatment. The aim of this study
Autor:
Masakazu Nagahori, Tadakazu Hisamatsu, Satoshi Tanida, Takayuki Matsumoto, Mitsuhiro Takeno, Yasuo Suzuki, Reiko Kunisaki, Kiyonori Kobayashi, Nobuhisa Mizuki, Kenji Watanabe, Fumiaki Ueno, Kazutaka Koganei, Katsuhiro Arai, Taku Kobayashi, Nagamu Inoue, Motoi Uchino
Publikováno v:
Journal of Gastroenterology
Behçet's disease (BD) is an intractable systemic inflammatory disease characterized by four main symptoms: oral and genital ulcers and ocular and cutaneous involvement. The Japanese diagnostic criteria of BD classify intestinal BD as a specific dise
Publikováno v:
Journal of Medical Economics. 23:80-85
Aims: Adalimumab, infliximab, and ustekinumab have been approved for patients with moderate-to-severe Crohn’s disease in Japan. This study compared the relative efficacy and cost-effectiveness of a...
Autor:
Yutaka Endo, Shintaro Hara, Takuya Masuda, Shotaro Umezawa, Fumiaki Ueno, Yoshihide Morikawa, Haruaki Nabeta, Mayuki Shirai, Toshifumi Hibi, Toshio Morizane, Atsushi Yoshida
Publikováno v:
Inflamm Intest Dis
A 40-year-old man with refractory ulcerative colitis (UC) was treated with tumor necrosis factor α inhibitor (anti-TNFα), infliximab. One month later, the chest computed tomography and laboratory test showed noninfectious interstitial lung disease
Autor:
Toshio Morizane, Atsushi Yoshida, Yutaka Endo, Toshifumi Hibi, Fumiaki Ueno, Katsuyoshi Matsuoka
Publikováno v:
Inflamm Intest Dis
Inflammatory Intestinal Diseases, Vol 6, Iss 2, Pp 117-122 (2021)
Inflammatory Intestinal Diseases, Vol 6, Iss 2, Pp 117-122 (2021)
Background: Anti-tumor necrosis factor-α (TNF-α) agents are effective for moderately to severely active ulcerative colitis (UC). Nonetheless, a proportion of patients fail to respond to these agents as therapy for induction of remission. Recent stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfddaa77be7f4f5506cbcfe6edd56981
https://europepmc.org/articles/PMC8160565/
https://europepmc.org/articles/PMC8160565/
Autor:
Susumu Okamoto, Tadakazu Hisamatsu, Haruhiko Ogata, Yasushi Iwao, Katsuyoshi Matsuoka, Tomoharu Yajima, Takanori Kanai, Fumiaki Ueno, Atsushi Yoshida, Nagamu Inoue, Jun Miyoshi, Makoto Naganuma, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 16, Iss 4, Pp 635-640 (2018)
Intestinal Research
Intestinal Research
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been demonstrated, a few patients paradoxically develop a se